Literature DB >> 11597743

The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.

F Masciopinto1, S Campagnoli, S Abrignani, Y Uematsu, P Pileri.   

Abstract

Human tetraspanin CD81 is a putative receptor for hepatitis C virus (HCV), because it has been shown to bind 'bona fide' HCV particles. CD81, as all tetraspanins, spans the membrane four times forming two extracellular loops: a small (SEL) and a large one (LEL). We have shown previously that a recombinant form of LEL is sufficient for binding HCV through the major envelope glycoprotein E2. The role of SEL in the CD81-HCV interaction was questioned. We found that transfectants expressing LEL alone bind the recombinant HCV-E2 protein at much lower levels than cells expressing the wild type CD81. And therefore whether SEL contributes to the CD81-HCV interaction or whether it influences the expression of LEL was examined. We have found that in the absence of SEL, LEL is expressed at significantly reduced levels on the cell surface because it is retained intracellularly, while HCV-E2 still binds LEL. Our data suggest that SEL of CD81 does not mediate interaction with HCV, but contributes to optimal cell surface expression of LEL by mediating translocation of the whole CD81 molecule to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597743     DOI: 10.1016/s0168-1702(01)00245-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

Review 1.  Tetraspanins in viral infections: a fundamental role in viral biology?

Authors:  F Martin; D M Roth; D A Jans; C W Pouton; L J Partridge; P N Monk; G W Moseley
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

2.  Cysteine residues in the large extracellular loop (EC2) are essential for the function of the stress-regulated glycoprotein M6a.

Authors:  Beata Fuchsova; María E Fernández; Julieta Alfonso; Alberto C Frasch
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

Review 3.  Roles of lipoprotein receptors in the entry of hepatitis C virus.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Takuo Yoshimoto; Huanxiang Zhang; Koji Murao
Journal:  World J Hepatol       Date:  2015-10-28

4.  Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles.

Authors:  R S Russell; K Kawaguchi; J-C Meunier; S Takikawa; K Faulk; J Bukh; R H Purcell; S U Emerson
Journal:  J Viral Hepat       Date:  2009-03-11       Impact factor: 3.728

5.  CellectSeq: In silico discovery of antibodies targeting integral membrane proteins combining in situ selections and next-generation sequencing.

Authors:  Abdellali Kelil; Eugenio Gallo; Sunandan Banerjee; Jarrett J Adams; Sachdev S Sidhu
Journal:  Commun Biol       Date:  2021-05-12

6.  Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution.

Authors:  Guangwei Min; Huaibin Wang; Tung-Tien Sun; Xiang-Peng Kong
Journal:  J Cell Biol       Date:  2006-06-19       Impact factor: 10.539

Review 7.  Hepatitis C Virus entry: the early steps in the viral replication cycle.

Authors:  Ali Sabahi
Journal:  Virol J       Date:  2009-07-30       Impact factor: 4.099

8.  Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.

Authors:  Sundaresan Rajesh; Pooja Sridhar; Birke Andrea Tews; Lucie Fénéant; Laurence Cocquerel; Douglas G Ward; Fedor Berditchevski; Michael Overduin
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

9.  Structural characterization of recombinant human CD81 produced in Pichia pastoris.

Authors:  Mohammed Jamshad; Sundaresan Rajesh; Zania Stamataki; Jane A McKeating; Timothy Dafforn; Michael Overduin; Roslyn M Bill
Journal:  Protein Expr Purif       Date:  2007-10-24       Impact factor: 1.650

10.  Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.

Authors:  Samir Yalaoui; Sergine Zougbédé; Stéphanie Charrin; Olivier Silvie; Cécile Arduise; Khemais Farhati; Claude Boucheix; Dominique Mazier; Eric Rubinstein; Patrick Froissard
Journal:  PLoS Pathog       Date:  2008-02-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.